Stromal cues regulate the pancreatic cancer epigenome and metabolome

Mara Sherman, Ruth T. Yu, Tiffany W. Tseng, Cristovao M. Sousa, Sihao Liu, Morgan L. Truitt, Nanhai He, Ning Ding, Christopher Liddle, Annette R. Atkins, Mathias Leblanc, Eric A. Collisson, John M. Asara, Alec C. Kimmelman, Michael Downes, Ronald M. Evans

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

A fibroinflammatory stromal reaction cooperates with oncogenic signaling to influence pancreatic ductal adenocarcinoma (PDAC) initiation, progression, and therapeutic outcome, yet the mechanistic underpinning of this crosstalk remains poorly understood. Here we show that stromal cues elicit an adaptive response in the cancer cell including the rapid mobilization of a transcriptional network implicated in accelerated growth, along with anabolic changes of an altered metabolome. The close overlap of stroma-induced changes in vitro with those previously shown to be regulated by oncogenic Kras in vivo suggests that oncogenic Kras signaling - a hallmark and key driver of PDAC - is contingent on stromal inputs. Mechanistically, stroma-activated cancer cells show widespread increases in histone acetylation at transcriptionally enhanced genes, implicating the PDAC epigenome as a presumptive point of convergence between these pathways and a potential therapeutic target. Notably, inhibition of the bromodomain and extraterminal (BET) family of epigenetic readers, and of Bromodomain-containing protein 2 (BRD2) in particular, blocks stroma-inducible transcriptional regulation in vitro and tumor progression in vivo. Our work suggests the existence of a molecular "AND-gate" such that tumor activation is the consequence of mutant Kras and stromal cues, providing insight into the role of the tumor microenvironment in the origin and treatment of Ras-driven tumors.

Original languageEnglish (US)
Pages (from-to)1129-1134
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number5
DOIs
StatePublished - Jan 31 2017

Fingerprint

Metabolome
Pancreatic Neoplasms
Cues
Adenocarcinoma
Neoplasms
Tumor Microenvironment
Gene Regulatory Networks
Acetylation
Epigenomics
Histones
Therapeutics
Growth
Genes
Proteins

Keywords

  • BRD2
  • Cancer metabolism
  • Histone acetylation
  • Pancreatic ductal adenocarcinoma
  • Tumor microenvironment

ASJC Scopus subject areas

  • General

Cite this

Stromal cues regulate the pancreatic cancer epigenome and metabolome. / Sherman, Mara; Yu, Ruth T.; Tseng, Tiffany W.; Sousa, Cristovao M.; Liu, Sihao; Truitt, Morgan L.; He, Nanhai; Ding, Ning; Liddle, Christopher; Atkins, Annette R.; Leblanc, Mathias; Collisson, Eric A.; Asara, John M.; Kimmelman, Alec C.; Downes, Michael; Evans, Ronald M.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 5, 31.01.2017, p. 1129-1134.

Research output: Contribution to journalArticle

Sherman, M, Yu, RT, Tseng, TW, Sousa, CM, Liu, S, Truitt, ML, He, N, Ding, N, Liddle, C, Atkins, AR, Leblanc, M, Collisson, EA, Asara, JM, Kimmelman, AC, Downes, M & Evans, RM 2017, 'Stromal cues regulate the pancreatic cancer epigenome and metabolome', Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 5, pp. 1129-1134. https://doi.org/10.1073/pnas.1620164114
Sherman, Mara ; Yu, Ruth T. ; Tseng, Tiffany W. ; Sousa, Cristovao M. ; Liu, Sihao ; Truitt, Morgan L. ; He, Nanhai ; Ding, Ning ; Liddle, Christopher ; Atkins, Annette R. ; Leblanc, Mathias ; Collisson, Eric A. ; Asara, John M. ; Kimmelman, Alec C. ; Downes, Michael ; Evans, Ronald M. / Stromal cues regulate the pancreatic cancer epigenome and metabolome. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 5. pp. 1129-1134.
@article{b5fab522edc14ebb8fc798d9a7a32e3b,
title = "Stromal cues regulate the pancreatic cancer epigenome and metabolome",
abstract = "A fibroinflammatory stromal reaction cooperates with oncogenic signaling to influence pancreatic ductal adenocarcinoma (PDAC) initiation, progression, and therapeutic outcome, yet the mechanistic underpinning of this crosstalk remains poorly understood. Here we show that stromal cues elicit an adaptive response in the cancer cell including the rapid mobilization of a transcriptional network implicated in accelerated growth, along with anabolic changes of an altered metabolome. The close overlap of stroma-induced changes in vitro with those previously shown to be regulated by oncogenic Kras in vivo suggests that oncogenic Kras signaling - a hallmark and key driver of PDAC - is contingent on stromal inputs. Mechanistically, stroma-activated cancer cells show widespread increases in histone acetylation at transcriptionally enhanced genes, implicating the PDAC epigenome as a presumptive point of convergence between these pathways and a potential therapeutic target. Notably, inhibition of the bromodomain and extraterminal (BET) family of epigenetic readers, and of Bromodomain-containing protein 2 (BRD2) in particular, blocks stroma-inducible transcriptional regulation in vitro and tumor progression in vivo. Our work suggests the existence of a molecular {"}AND-gate{"} such that tumor activation is the consequence of mutant Kras and stromal cues, providing insight into the role of the tumor microenvironment in the origin and treatment of Ras-driven tumors.",
keywords = "BRD2, Cancer metabolism, Histone acetylation, Pancreatic ductal adenocarcinoma, Tumor microenvironment",
author = "Mara Sherman and Yu, {Ruth T.} and Tseng, {Tiffany W.} and Sousa, {Cristovao M.} and Sihao Liu and Truitt, {Morgan L.} and Nanhai He and Ning Ding and Christopher Liddle and Atkins, {Annette R.} and Mathias Leblanc and Collisson, {Eric A.} and Asara, {John M.} and Kimmelman, {Alec C.} and Michael Downes and Evans, {Ronald M.}",
year = "2017",
month = "1",
day = "31",
doi = "10.1073/pnas.1620164114",
language = "English (US)",
volume = "114",
pages = "1129--1134",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "5",

}

TY - JOUR

T1 - Stromal cues regulate the pancreatic cancer epigenome and metabolome

AU - Sherman, Mara

AU - Yu, Ruth T.

AU - Tseng, Tiffany W.

AU - Sousa, Cristovao M.

AU - Liu, Sihao

AU - Truitt, Morgan L.

AU - He, Nanhai

AU - Ding, Ning

AU - Liddle, Christopher

AU - Atkins, Annette R.

AU - Leblanc, Mathias

AU - Collisson, Eric A.

AU - Asara, John M.

AU - Kimmelman, Alec C.

AU - Downes, Michael

AU - Evans, Ronald M.

PY - 2017/1/31

Y1 - 2017/1/31

N2 - A fibroinflammatory stromal reaction cooperates with oncogenic signaling to influence pancreatic ductal adenocarcinoma (PDAC) initiation, progression, and therapeutic outcome, yet the mechanistic underpinning of this crosstalk remains poorly understood. Here we show that stromal cues elicit an adaptive response in the cancer cell including the rapid mobilization of a transcriptional network implicated in accelerated growth, along with anabolic changes of an altered metabolome. The close overlap of stroma-induced changes in vitro with those previously shown to be regulated by oncogenic Kras in vivo suggests that oncogenic Kras signaling - a hallmark and key driver of PDAC - is contingent on stromal inputs. Mechanistically, stroma-activated cancer cells show widespread increases in histone acetylation at transcriptionally enhanced genes, implicating the PDAC epigenome as a presumptive point of convergence between these pathways and a potential therapeutic target. Notably, inhibition of the bromodomain and extraterminal (BET) family of epigenetic readers, and of Bromodomain-containing protein 2 (BRD2) in particular, blocks stroma-inducible transcriptional regulation in vitro and tumor progression in vivo. Our work suggests the existence of a molecular "AND-gate" such that tumor activation is the consequence of mutant Kras and stromal cues, providing insight into the role of the tumor microenvironment in the origin and treatment of Ras-driven tumors.

AB - A fibroinflammatory stromal reaction cooperates with oncogenic signaling to influence pancreatic ductal adenocarcinoma (PDAC) initiation, progression, and therapeutic outcome, yet the mechanistic underpinning of this crosstalk remains poorly understood. Here we show that stromal cues elicit an adaptive response in the cancer cell including the rapid mobilization of a transcriptional network implicated in accelerated growth, along with anabolic changes of an altered metabolome. The close overlap of stroma-induced changes in vitro with those previously shown to be regulated by oncogenic Kras in vivo suggests that oncogenic Kras signaling - a hallmark and key driver of PDAC - is contingent on stromal inputs. Mechanistically, stroma-activated cancer cells show widespread increases in histone acetylation at transcriptionally enhanced genes, implicating the PDAC epigenome as a presumptive point of convergence between these pathways and a potential therapeutic target. Notably, inhibition of the bromodomain and extraterminal (BET) family of epigenetic readers, and of Bromodomain-containing protein 2 (BRD2) in particular, blocks stroma-inducible transcriptional regulation in vitro and tumor progression in vivo. Our work suggests the existence of a molecular "AND-gate" such that tumor activation is the consequence of mutant Kras and stromal cues, providing insight into the role of the tumor microenvironment in the origin and treatment of Ras-driven tumors.

KW - BRD2

KW - Cancer metabolism

KW - Histone acetylation

KW - Pancreatic ductal adenocarcinoma

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85011295507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011295507&partnerID=8YFLogxK

U2 - 10.1073/pnas.1620164114

DO - 10.1073/pnas.1620164114

M3 - Article

C2 - 28096419

AN - SCOPUS:85011295507

VL - 114

SP - 1129

EP - 1134

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 5

ER -